FDA Approved: PARICALCITOL — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for paricalcitol from Accord Healthcare, resulting in a label change for this chronic kidney disease–related therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

SUPPL AP for PARICALCITOL (PARICALCITOL)